Literature DB >> 7980402

Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes.

M Zeggari1, J P Esteve, I Rauly, C Cambillau, H Mazarguil, M Dufresne, L Pradayrol, J A Chayvialle, N Vaysse, C Susini.   

Abstract

We have previously shown that somatostatin promotes the stimulation of a membrane tyrosine phosphatase activity in pancreatic cells. To gain insight into the mechanism of somatostatin action, we purified somatostatin-receptor complexes from somatostatin 28-prelabelled rat pancreatic plasma membranes by immunoaffinity chromatography using immobilized antibodies raised against the N-terminal part of somatostatin 28, somatostatin 28 (1-14), which is not involved in receptor-binding-site recognition. After SDS gel electrophoresis a band with a molecular mass of 87 kDa was identified in the affinity-purified material as the somatostatin receptor. The 87 kDa protein was not observed when the membrane receptors were solubilized in a free unoccupied or somatostatin 14-occupied form, or when nonimmune serum replaced the anti-[somatostatin 28 (1-14)] anti-serum. Somatostatin 14 inhibited the appearance of the 87 kDa protein in the same range of concentrations that inhibit radioligand binding on pancreatic membranes. After somatostatin 28 treatment of membranes, purified somatostatin receptor preparations exhibited an elevated tyrosine phosphatase activity that dephosphorylated phosphorylated epidermal growth factor receptor and poly(Glu,Tyr). This activity was related to the presence of somatostatin receptors in purified material. It was increased by dithiothreitol and inhibited by orthovanadate. In purified material containing somatostatin receptors, anti-[Src homology 2 domains (SH2)]-containing tyrosine phosphatase SHPTP1 polyclonal antibodies identified a protein of 66 kDa which was not detected in the absence of somatostatin receptor. Furthermore, the anti-SHPTP1 antibodies immunoprecipitated specific somatostatin receptors from somatostatin-prelabelled pancreatic membranes and from untreated membranes. These results indicate that a 66 kDa tyrosine phosphatase related to SHPTP1 co-purifies with the pancreatic somatostatin receptors, and suggest that this protein is associated with somatostatin receptors at the membrane level.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980402      PMCID: PMC1137347          DOI: 10.1042/bj3030441

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 2.  Somatostatin (second of two parts).

Authors:  S Reichlin
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

3.  Evidence for two somatostatin-14 receptor types in rat brain cortex.

Authors:  J C Reubi
Journal:  Neurosci Lett       Date:  1984-08-31       Impact factor: 3.046

4.  A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells.

Authors:  K H Jakobs; K Aktories; G Schultz
Journal:  Nature       Date:  1983 May 12-18       Impact factor: 49.962

5.  A one-step purification of membrane proteins using a high efficiency immunomatrix.

Authors:  C Schneider; R A Newman; D R Sutherland; U Asser; M F Greaves
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

6.  Rapid electrotransfer of proteins from polyacrylamide gel to nitrocellulose membrane using surface-conductive glass as anode.

Authors:  M Svoboda; S Meuris; C Robyn; J Christophe
Journal:  Anal Biochem       Date:  1985-11-15       Impact factor: 3.365

7.  Intracellular receptor for somatostatin in gastric mucosal cells: decomposition and reconstitution of somatostatin-stimulated phosphoprotein phosphatases.

Authors:  F J Reyl; M J Lewin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  Binding of somatostatin to guinea-pig pancreatic membranes: regulation by ions.

Authors:  D Taparel; J P Estève; C Susini; N Vaysse; D Balas; G Berthon; E Wunsch; A Ribet
Journal:  Biochem Biophys Res Commun       Date:  1983-09-30       Impact factor: 3.575

10.  Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28.

Authors:  A M O'Carroll; S J Lolait; M König; L C Mahan
Journal:  Mol Pharmacol       Date:  1992-12       Impact factor: 4.436

View more
  7 in total

1.  Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin.

Authors:  D B Reardon; S L Wood; D L Brautigan; G I Bell; P Dent; T W Sturgill
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 2.  Somatostatin.

Authors:  T Reisine
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

Review 3.  Molecular pharmacology of somatostatin receptor subtypes.

Authors:  Y C Patel
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 4.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

5.  Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.

Authors:  I Rauly; N Saint-Laurent; N Delesque; L Buscail; J P Estéve; N Vaysse; C Susini
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

6.  Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.

Authors:  L Buscail; J P Estève; N Saint-Laurent; V Bertrand; T Reisine; A M O'Carroll; G I Bell; A V Schally; N Vaysse; C Susini
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.

Authors:  K Bedecs; N Elbaz; M Sutren; M Masson; C Susini; A D Strosberg; C Nahmias
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.